Bradykinesia is a prominent phenotype of Parkinson's disease, depression, and other neurological conditions. Disruption of dopamine (DA) transmission plays an important role, but progress in understanding the exact mechanisms driving slowness of movement has been impeded due to the heterogeneity of DA receptor distribution on multiple cell types within the striatum. Here we show that selective deletion of DA D2 receptors (D2Rs) from indirect-pathway medium spiny neurons (iMSNs) is sufficient to impair locomotor activity, phenocopying DA depletion models of Parkinson's disease, despite this mouse model having intact DA transmission. There was a robust enhancement of GABAergic transmission and a reduction of in vivo firing in striatal and pallidal neurons. Mimicking D2R signaling in iMSNs with Gi-DREADDs restored the level of tonic GABAergic transmission and rescued the motor deficit. These findings indicate that DA, through D2R activation in iMSNs, regulates motor output by constraining the strength of GABAergic transmission.
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In Brief
Lemos et al. find that targeted deletion of dopamine D2 receptors from indirectpathway medium spiny neurons (iMSNs) leads to enhanced GABAergic transmission downstream of iMSNs. This enhanced GABAergic tone causes a Parkinsonian-like motor deficit similar to dopamine depletion models.
INTRODUCTION Dopamine (DA) depletion, caused by pharmacological agents or genetic models of DA neuron degeneration, produces a pronounced motor deficit that closely resembles the motor symptoms characteristic of Parkinson's disease (Bergman and Deuschl, 2002; Deumens et al., 2002; Lovinger, 2010; Palmiter, 2008; Schultz, 1982; Surmeier et al., 2014) . However, this basic research has struggled to accurately and consistently relate the motor deficits produced by DA depletion to specific changes in striatal neuronal activity and circuit function. This is owing, in large part, to technical limitations such as the experimental variability inherent to 6-OHDA lesions (Deumens et al., 2002; Vandeputte et al., 2010) , in addition to the biological complexity, such as the heterogeneity of DA receptor expression within the basal ganglia .
DA D2 receptors (D2Rs) are critical to motor output because global deletion of D2Rs leads to similar motor deficits as those seen after DA depletion (Baik et al., 1995; Kelly et al., 1998; Rubinstein et al., 1990) . However, in the striatum alone, D2Rs are expressed on at least five different types of neurons: indirect-pathway medium spiny neurons (iMSNs), cholinergic interneurons, a subset of GABA interneurons, and afferents to the striatum from DA and prefrontal cortex neurons (Bamford et al., 2004; Bello et al., 2011; Centonze et al., 2003; Maurice et al., 2004; Surmeier et al., 2011) . It is unclear whether ubiquitous activation of all these striatal D2Rs or selective activation of a subset of D2Rs is responsible for generating the motor deficits of DA depletion models. Furthermore, it is unknown whether D2Rs expressed in the cortex and other non-striatal regions that receive projections from midbrain DA neurons also contribute to this motor phenotype. In this study, we generated a mouse line with a precise genetic manipulation that allows for reliable titration of the levels of D2Rs on iMSNs by crossing conditional Drd2 loxP/loxP mice with mice expressing Cre recombinase selectivity in striatal iMSNs (Adora2A-Cre +/À ). This mouse line, referred to as iMSN-Drd2KO, exhibits bradykinesia while showing normal DA release properties, indicating that downregulation of D2R function in iMSNs is sufficient to recapitulate the motor impairments of DA depletion models. Based on the ''go-no go'' model of basal ganglia function, direct-pathway MSNs (dMSNs) and iMSNs exert opposite effects on motor output, where increased activity of dMSNs facilitates movement and increased activity of iMSNs suppresses movement (Albin et al., 1989; DeLong, 1972; Delong et al., 1984; Gerfen and Surmeier, 2011) . Indeed, manipulations of dMSN and iMSN activity have provided strong support for this model (Bateup et al., 2010; Durieux et al., 2009; Kravitz et al., 2010) . Furthermore, the model posits that DA in the striatum enhances locomotion mainly via activation of G s/olfcoupled DA D1Rs expressed by dMSNs and activation of G i/o -coupled D2Rs expressed by iMSNs (Durieux et al., 2012) . This model is the basis for one of the current hypotheses of Parkinson's disease, which postulates that decreased activity of dMSNs and increased activity of iMSNs, resulting from a lack of D1R and D2R activation, respectively, is responsible for the motor impairment. Several studies report enhanced in vivo somatic firing rate after 6-OHDA lesion, although this finding has been inconsistent across studies Chang et al., 2006; Cho et al., 2002; Costa et al., 2006; Hull et al., 1974; Kish et al., 1999) . It is then still unclear how striatal circuit activity changes during the motor impairment and whether these changes are causative or rather homeostatic alterations aimed at compensating for the motor dysfunction. In this study, targeted deletion of D2Rs to striatal iMSNs is performed to parse the specific role of these receptors in controlling neuronal excitability, in vivo MSN firing, and inhibitory transmission, and to determine how these cellular changes may relate to the observed motor impairment, one of the main symptoms that defines Parkinson's disease.
RESULTS

Selective Deletion of D2Rs from iMSNs Impairs Spontaneous Locomotion
Mice carrying the conditional Drd2 allele (Drd2 loxP/loxP ) were crossed with BAC transgenic Adora2A-Cre +/À mice to generate mice lacking D2Rs selectively in iMSNs throughout the striatum (iMSN-Drd2KO), while preserving other striatal and non-striatal D2Rs. Adora2A-Cre +/À transgenic mice provide specific Cre expression in iMSNs (>80% co-expression with met-enkaphalin) with no expression in dMSNs, cholinergic interneurons, and midbrain DA neurons ( Figure S1 , available online). There was a pronounced gene-dependent reduction of Drd2 mRNA in striatal tissue for iMSN-Drd2HET (Drd2 WT/loxP 3 Adora2A-Cre +/À ) ($40%) and iMSN-Drd2KO mice (>80%) relative to Drd2 loxP/loxP mice (one-way ANOVA, F 2, 8 = 83.75, p < 0.0001, n = 3-5 mice) with no reduction in Drd1 mRNA levels (one-way ANOVA, p = 0.43; Figure 1A ). Locomotor activity in the home cage was reduced by >50% in both iMSN-Drd2HET and iMSN-Drd2KO mice compared to control Drd2 loxP/loxP littermates (time 3 genotype interaction, two-way repeated measures ANOVA, F 46,759 = 4.635, p < 0.0001, n = 9-14; Figure 1B ). When placed in a novel open field chamber, iMSN-Drd2KO mice spent more time immobile (hypokinesia) and were slower when mobile (bradykinesia), contributing to an overall lower distance traveled (85% ± 3% versus 67% ± 3% immobile for iMSN-Drd2KO and Drd2 loxP/loxP , respectively; speed when mobile [>2 cm/s] = 4.5 cm/s versus 6 cm/s; one-way ANOVA, F 2,59 = 13.9 and 29.9, respectively, p < 0.0001, n = 9-28; Figure 1C ). In addition, iMSN-Drd2KO mice showed impaired performance on a motor skill task assayed using the rotarod ( Figure 1D ). iMSN-Drd2HET mice displayed an intermediate phenotype in both assays (post hoc tests, p < 0.05 compared to Drd2 loxP/loxP and iMSN-Drd2KO; n = 9-28; Figures 1C and   1D ), demonstrating haploinsufficiency and the ability of this genetic model to tightly control the expression level of D2Rs and titrate the motor phenotype. These results indicate that reduction of striatal D2R levels specifically in iMSNs is sufficient to reproduce the motor deficits of global D2R knockout mice and DA depletion models (Baik et al., 1995; Kelly et al., 1998; Rubinstein et al., 1990) and is opposite to the phenotype following targeted deletion of D2 autoreceptors (Anzalone et al., 2012; Bello et al., 2011) . Pre-clinical studies using 6-OHDA lesions produce motor impairments that are lessened by salient stimuli (Keefe et al., 1989; Rodríguez Díaz et al., 2001 ), similar to the paradoxical kinesia observed in Parkinson's patients (Bie nkiewicz et al., 2013) . Interestingly, we also noticed that iMSN-Drd2KO mice showed less motor impairment during the novelty phase of the open field assay (the first minute), and iMSN-Drd2HET displayed similar locomotor response to control Drd2 loxP/loxP mice during this first minute of open field exposure (post hoc test, p = 0.93, n = 9-24; Figures  1C and S2 ). These observations suggested that environmental salience could reduce the impact of the motor impairment. We performed two additional experiments to more directly evaluate the impact of environmental salience. First, we tested whether exposure to a novel object, an appetitive stimulus known to evoke phasic DA (Fink and Smith, 1980; Legault and Wise, 2001) , would facilitate locomotion in iMSN-Drd2KO mice. When a novel object was introduced in the center of the open field chamber, iMSN-Drd2KO mice spent more time in the object's perimeter and traveled larger distances around the object compared to Drd2 loxP/loxP mice (t tests, p = 0.04, n = 20-21). In this context, their speed around the object did not differ from control littermates (t test, p = 0.96, n = 20-21; Figures 1E and S3 ). Second, we measured motor activity of the same two groups of mice (iMSN-Drd2KO and control Drd2 loxP/loxP ) in two environments that carried different motivational salience: a cylindrical empty chamber and a cylindrical chamber of identical dimensions filled with water. Spontaneous locomotion was measured for 15 min over a 2 day period, counterbalanced across animals. In the empty chamber, iMSNDrd2KO mice displayed a similar motor deficit as seen in the novel open field described above ( Figure 1F ). In contrast, during forced swim, iMSN-Drd2KO mice did not exhibit significant differences in speed or distance traveled compared to control Drd2 loxP/loxP littermates (t tests, p = 0.4, n = 9-11; Figure 1F ).
Collectively, the results indicate that the motor activity stimulated by salient stimuli is normal, or even possibly enhanced, in iMSN-Drd2KO compared to control littermates, again replicating the motor phenotype of DA depletion models.
To further evaluate the spatio-temporal dependence of the D2R deletion on the motor impairment, D2R deletion was restricted to the nucleus accumbens (NAc) of adult mice using bilateral stereotaxic injections of AAV viral vectors expressing Cre recombinase in the NAc of adult (>post-natal day [p]60) Drd2 loxP/loxP mice (Figures 2A and 2B ). This manipulation, while not selective for iMSNs, produced an 80% reduction of Drd2 mRNA levels in the NAc ( Figure 2C ) and minimizes possible compensatory changes caused by lack of D2Rs during brain development. Knockdown of D2Rs in the NAc decreased homecage locomotion (time 3 viral type interaction, two-way repeated measures ANOVA, F 23,276 = 1.83, p = 0.01; main effect of viral type, F 23,276 = 6.65, p = 0.008, n = 5-9; Figure 2D ). Moreover, NAc-Drd2 knockdown reduced horizontal locomotor activity in a novel locomotor chamber compared to GFP-expressing mice (two-way repeated measures ANOVA, main effect of viral type, F 1,20 = 17.68, p = 0.004, n = 10-12; Figure 2E ). The pattern of locomotor activity between naive Drd2 loxP/loxP control mice and Drd2 loxP/loxP expressing GFP viral particles was nearly identical (two-way repeated measures ANOVA, F 11,308 = 0.5, p = 0.55, n = 12-18). Acute knockdown of D2Rs in the NAc completely recapitulated the locomotor deficit observed in iMSN-Drd2KO mice in this particular behavioral assay (twoway repeated measures ANOVA, F 11,209 = 0.5, p = 0.63, n = 10-11). However, acute knockdown of D2Rs in the NAc did not impair motor skill performance or motor skill learning on a rotarod (two-way repeated measures ANOVA, F 25,325 = 0.73, p = 0.39, n = 6-9; Figure 2F ). These results are consistent with other studies that suggest a regional dissociation between spontaneous locomotion and motor skill learning (Durieux et al., 2012) and are complementary to recent findings showing increased locomotion following D2R overexpression in the NAc (Gallo et al., 2015) . Taken together, these results demonstrate that the locomotor deficit does not require absence of D2Rs (B) Locomotion measured in homecage for Drd2 loxP/loxP (black), iMSN-Drd2HET (pink), and iMSN-Drd2KO (red) mice; n = 9-14.
Object Exploration
(C) Top: representative track traces for the three genotypes. Middle: total distance traveled over 30 min, during first minute (''novelty phase''), and average speed during last 20 min (''sustained phase'') for the three genotypes. Bottom: speed when mobile (dashed line at 2 cm/s threshold) and percent time immobile for the three genotypes; n = 9-28, *p < 0.05,**p < 0.01,***p < 0.001 in post hoc t tests. (D) Latency to fall in the rotarod assay for the three genotypes; n = 8-10, ###p < 0.001, genotype 3 latency interaction.
(E) Representative traces, average speed, and total distance of exploratory behavior around novel object for Drd2 loxP/loxP and iMSN-Drd2KO; n = 20-21, *p < 0.05, t test. (F) Representative traces, total distance traveled, and average speed for Drd2 loxP/loxP and iMSN-Drd2KO animals in the forced swim test; n = 9-11, **p < 0.01, t test. All data expressed as mean ± SEM. throughout development. Moreover, it suggests that manipulating DA transmission in the NAc alone can alter movement.
Evoked DA Release and D2 Autoreceptor Modulation Are Intact in iMSN-Drd2KO Mice Fast-scan cyclic voltammetry was used to measure DA signals in both the dorsal striatum (DS) and the NAc in brain slices from iMSN-Drd2KO and control Drd2 loxP/loxP mice. In the DS, the DA concentrations evoked by one pulse stimulation were higher than the NAc, and there were no differences between genotypes (two-way ANOVA; main effect of region, F 1,36 = 10.52, p = 0.003; no region 3 genotype interaction, F 1,36 = 1.3EÀ5, p = 0.99, n = 7-14; Figures 3A and 3B ). Single-pulse stimulation evoked the maximal DA concentration transient at 0.5 ms duration in both genotypes, which plateaued with longer durations (two-way repeated measures ANOVA; main effect of stimulation duration, F 5,60 = 10.89, p < 0.0001; Figure 3C ). There was no difference between genotypes in the peak DA concentration following 20-pulse stimulation or in the 1 pulse:20 pulse ratio, which was higher in the NAc than in the DS (two-way ANOVA; main effect of region, F 1,36 = 13.36, p = 0.0008; no region 3 genotype interaction, F 1,36 = 0.1371, p = 0.7, n = 7-14; Figures 3D and 3E -GFP mice; n = 6-9. All data expressed as mean ± SEM.
increased DA transients evoked by trains, and, as expected, the increase was greater in the NAc than in the DS (twoway repeated measures ANOVA; main effect of region, F 1,12 = 15.13, p = 0.002; Figures 3F and 3G) . Importantly, the effect of sulpiride was similar in both genotypes (two-way ANOVA; region 3 genotype interaction, F 1,25 = 0.33, p = 0.53, n = 5-8; Figures 3F and 3G), as was the effect of a D2-like agonist, quinpirole, at the IC 50 concentration (0.03 mM) or maximal concentration of 1 mM (twoway ANOVA; drug concentration 3 genotype interaction, F 2,24 = 1.47, p = 0.25, n = 4-9; Figures 3H and 3I). Thus, the DA release properties and the modulation of DA transmission by D2R autoreceptors are intact in this mouse model lacking D2Rs in striatal neurons.
Reduction of In Vivo Firing in the Basal Ganglia
Based on previous studies, we hypothesized that increased firing rate of iMSNs may account for the motor deficits of iMSN-Drd2KO mice (Hernandez-Lopez et al., 2000; Kravitz et al., 2010; Surmeier and Kitai, 1993) . To test this hypothesis, we performed in vivo recordings in the dorsal striatum of freely moving control and iMSN-Drd2KO mice. Single-unit recordings from MSNs and interneurons were sorted based on their waveform and firing rates ( Figure S4 ). The same motor deficit was seen in iMSN-Drd2KO mice, from whom we recorded singleunit activity, compared to control mice ( Figure S4 ). The average firing rate per MSN was not significantly different between genotypes (control, 0.86 ± 0.1 Hz; iMSN-Drd2KO, 0.76 ± 0.10 Hz; t test, p = 0.42, n = 107-117 cells; Figures 4A and 4B ). However, there was a significant variation in the number of cells recorded per animal, including a disproportionally large number of neurons recorded from one low firing control. We therefore assessed the average firing rate per animal, which was significantly lower in iMSN-Drd2KO mice relative to controls (control, 0.91 ± 0.11 Hz; iMSN-Drd2KO, 0.46 ± 0.11 Hz; t test, p = 0.02, n = 5-7 mice; Figure 4C ). Furthermore, there was no evidence of a bimodal distribution of firing rates in either genotype, indicating an overall decrease in firing rate across the two subpop- ulations of MSNs in iMSN-Drd2KO mice. To examine firing rates of iMSNs more specifically, we expressed channelrhodopsin (ChR2) in a cre-dependent manner and used optogenetic stimulation to identify single units arising specifically from iMSNs (optogenetic tagging).
For these experiments, Adora2A-Cre
mice, which display similar locomotor activity as Drd2 loxP/loxP littermates, were used as the control group ( Figure S2 ). The firing rates of tagged iMSNs were also significantly lower in the iMSN-DrdKO mice (Adora2A-Cre +/À , 0.91 ± 0.23 Hz versus iMSN-DrdKO, 0.33 ± 0.11 Hz; one-tailed t test, p = 0.03, n = 5-6 cells; Figures 4D-4F ), consistent with the results shown above. We were also able to record from a handful of putative GABAergic interneurons (based on fast waveform; Figure S4 ). There was also a significant decrease in firing in this putative interneuron population (control, 16.1 ± 3.5 Hz; iMSN-Drd2KO, 4.6 ± 1.3 Hz; t test, p = 0.02, n = 9-11 cells; Figure 4G ). Taken together, we conclude that firing of both iMSNs and dMSNs is depressed in iMSN-Drd2KO mice, in contrast to our prediction that firing of iMSNs would be heightened following the loss of D2Rs. Furthermore, the reduction in putative interneuron firing indicates an overall depression in striatal network activity.
The in vivo firing of neurons in the globus pallidus external (GPe), the downstream target of iMSNs, was assessed next. There was a dramatic decrease in the firing rate of GPe neurons in iMSN-Drd2KO mice compared to controls (control, 30.2 ± 5.1 Hz; iMSN-Drd2KO, 14.3 ± 2.4 Hz; p = 0.002, n = 35-49 cells; Figures 4H and 4I ). This finding is consistent with the motor deficit of these mice but paradoxical when considering the decreased firing of iMSNs. To probe the cellular mechanism(s) underlying the changes in basal ganglia activity, we turned to slice electrophysiology where we were able to isolate currents and selectively record from dMSNs and iMSNs.
Decreased Excitability of iMSNs
Changes in intrinsic excitability of MSNs might contribute to the observed reduction of in vivo firing rate, particularly since it has been demonstrated that overexpression of D2Rs in the striatum enhances intrinsic excitability (Cazorla et al., 2012 activity as Drd2 loxP/loxP mice ( Figure S2 ). The intrinsic excitability was measured using whole-cell recordings from MSNs in brain slices in the presence of synaptic blockers. Consistent with previous studies Kreitzer and Malenka, 2007) , iMSNs showed higher intrinsic excitability than dMSNs in control Drd1-tdTomato;Drd2 loxP/loxP mice (two-way repeated measures ANOVA; current 3 cell type interaction, F 12, 444 = 3.149, p = 0.0003, n = 16-23). However, in iMSN-Drd2KO mice, there was a significant rightward shift in the current input-AP frequency relationship in iMSNs recorded from either the DS or the NAc, demonstrating a reduction in excitability (DS, two-way repeated measures ANOVA, current 3 genotype interaction, F 12,156 = 3.45, p < 0.0001, n = 6-9; NAc, two-way repeated measures ANOVA, current 3 genotype interaction, F 12,228 = 3.34, p = 0.0002, n = 7-14; Figure 5C ). The intrinsic excitability of dMSNs was similar between genotypes for both the DS and NAc (two-way repeated measures ANOVA; current 3 genotype interaction, p > 0.05, n = 5-9; Figure 5D ). Thus, iMSNs were not more excitable than dMSNs in iMSN-Drd2KO mice. These surprising findings prompted us to revisit the basic question of whether acute D2R activation can induce direct changes in membrane properties in the absence of synaptic inputs. We assessed the effect of acute application of the D2-like receptor agonist quinpirole (1 mM) on input-output curve of iMSNs in control mice in the presence of synaptic blockers. In cells recorded from either the DS or the NAc, acute quinpirole administration had no effect on the input-output curve of iMSNs (DS, two-way repeated measures ANOVA, current 3 drug interaction, F 12,156 = 3.45, p = 0.84, n = 6; NAc, two-way repeated measures ANOVA, current 3 drug interaction, F 12,144 = 0.028, p = 1.0, n = 7; Figure 5E ). These findings indicate that acute D2R activation has no direct effect on the threshold to fire action potentials by iMSNs under these recording conditions.
The reduction of intrinsic excitability of iMSNs is consistent with reduced in vivo firing of these neurons, and it could be the underlying mechanism. However, this result cannot account for all the circuit perturbations observed in iMSN-Drd2KO mice, such as the decrease in GPe firing and dMSN firing, two downstream targets of iMSNs. Recent studies have demonstrated an enhanced GABAergic tone within the basal ganglia following 6-OHDA lesion (Borgkvist et al., 2015; Fan et al., 2012) . We therefore assessed the state of GABAergic transmission at the output of iMSNs.
Enhanced GABAergic Transmission in the Striatum and the GPe We measured tonic and synaptic GABAergic transmission in putative dMSNs and iMSNs of Drd2 loxP/loxP and iMSN-Drd2KO mice crossed with Drd1-tdTomato mice. For clarity, we combined data from the DS and NAc, when possible, and placed separated regional data in the Supplemental Information. GABA-A-mediated tonic conductances have been studied across several brain regions, and in the cerebellum and olfactory bulb have been found to be important regulators of neuronal excitability in vivo. High-affinity GABA-A receptors, containing a5 or d subunits, underlie these tonic conductances, which are typically measured as a change in holding current of the cell as well as a change in current noise (Bright and Smart, 2013) . The most consistent finding across striatal regions was the presence of a larger density of tonic inward current in dMSNs from iMSNDrd2KO mice (À0.6 ± 0.1 pA/pF for Drd2 loxP/loxP versus À1.0 ± 0.1 pA/pF for iMSN-Drd2KO; p = 0.002, n = 14-25; Figures  6A-6C , S5, and S6). This increased tonic inward current is not due to changes in K + conductance since the recordings were performed using a Cs + -based internal solution. The tonic inward current was inhibited by gabazine (10 mM) in both genotypes, indicating that GABA-A receptor activation contributes to this current (one-sample t tests versus 100%, p < 0.05). Importantly, the effect of gabazine on the tonic current was much more pronounced in iMSN-Drd2KO mice, effectively eliminating the difference in holding current density between controls and iMSN-Drd2KO mice (two-way repeated measures ANOVA; time 3 genotype interaction, F 1,15 = 15.90, p = 0.0012, n = 8-9; Figures 6D and 6E ). Evaluating the data in another way, we found that gabazine blocked 25% ± 4% of the holding current recorded from dMSNs compared to only 11% ± 4% of the holding current recorded in dMSNs in control littermates Drd2 loxP/loxP (p < 0.011; Figure 6F ). There was no difference in tonic inward current between genotypes for either dMSNs or iMSNs in the presence of gabazine and when using 100% CsMeSO 3 -based internal (p = 0.84 and 0.86 for dMSNs and iMSNs, respectively, n = 12-16; Figure 6G ). Thus, blocking GABA-A-receptor-mediated transmission revealed an enhanced tonic GABA-A-mediated current in dMSNs from knockout (KO) mice. When examining fast synaptic GABA-A-mediated transmission, we found that the frequency of miniature inhibitory postsynaptic currents (mIPSCs) recorded from dMSNs was significantly increased in iMSN-Drd2KO mice (1.9 ± 0.2 Hz in Drd2 loxP/loxP versus 2.4 ± 0.2 Hz in iMSN-Drd2KO; p = 0.029, n = 24-25). Similarly, mIPSC frequency was also increased in iMSNs (2.0 ± 0.2 Hz for Drd2 loxP/loxP versus 3.1 ± 0.3 Hz for iMSN-Drd2KO; p = 0.0066, n = 14-15; Figure 6H ). The increased frequency was observed for small and large amplitude events, though it was most consistent for event amplitudes ranging from 10 to 30 pA ( Figure 6I ). The amplitude of mIPSCs was also increased in dMSNs (29 ± 2 pA for Drd2 loxP/loxP versus 36 ± 3 pA for iMSNDrd2KO; p = 0.015, n = 2430 pA 25; Figure 6H ). Interestingly, there were cell-type-specific regional differences throughout the striatum (Figures S5 and S6) , which may be due to differences in the contribution of GABAergic inputs emanating from MSN axon collaterals, interneurons, and pallidal neurons onto MSNs to the overall mIPSC measurement. Yet this basic finding of enhanced fast synaptic GABAergic transmission was consistent between the DS and NAc. Taken together, these data demonstrate that deletion of D2Rs from iMSNs induces a robust enhancement of tonic and fast synaptic GABAergic transmission onto striatal neurons that may shunt excitation and contribute to decreased MSN firing in vivo.
We reasoned that if enhanced GABA release from iMSNs was contributing to the GABA tone in the striatum of IMSN-Drd2KO mice, a similar enhancement in GABAergic transmission should be observed in the GPe, the target of long-range projections from iMSNs. Under the exact same recording conditions as above, there was a robust increase in mIPSC frequency in GPe neurons recorded from iMSN-Drd2KO mice (6.6 ± 0.8 Hz in Drd2 loxP/loxP versus 13.9 ± 2.4 Hz in iMSN-Drd2KO; p = 0.005, n = 17-19; Figures 6J-6L ). In contrast to the striatum, we did not find any change in amplitude (52.3 ± 3.0 pA in Drd2 loxP/loxP versus 48.4 ± 3.0 Hz in iMSN-Drd2KO; p = 0.37; Figure 6L ) or difference in holding current density (À1.1 ± 0.2 pA/pF in Drd2 loxP/loxP versus À1.3 ± 0.3 pA/pF in iMSN-Drd2KO; p = 0.69, n = 17-19). This increase in mIPSC frequency, but not amplitude, is consistent with an enhancement in probability of release at GABAergic terminals as a result of D2R deletion from iMSNs.
Miniature excitatory postsynaptic currents (mEPSCs) were also recorded from iMSNs and dMSNs in the dorsal striatum. No change in mEPSC frequency (t test, p = 0.38) or amplitude (p = 0.16, n = 12-15; Figure S7 ) was found in iMSNs of iMSNDrd2KO mice compared to littermate controls. Interestingly, we did observe a significant increase in mEPSC frequency in dMSNs (p = 0.009), and this was accompanied by a small, but significant, change in mEPSC amplitude (p = 0.006, n = 14-16; Figure S7 ). These data suggest a restructuring of glutamatergic connectivity following chronic D2R deletion from iMSNs. In general terms, these results are in agreement with results reported following DA depletion models, but in those models the change was preferentially observed in iMSNs (Day et al., 2006; Kita and Kita, 2011) .
Enhanced Inhibition in the Striatum Drives the Motor Deficit
To test whether the enhanced intrastriatal GABAergic transmission was a key driver of the motor deficit observed in iMSN-Drd2KO mice, we conducted bilateral microinfusion experiments in which a small volume of a low dose of picrotoxin (125-150 nL, 100 mM) was infused into the striatum of Drd2 loxP/loxP and iMSN-Drd2KO while locomotion was assessed. Mice were tethered to an infusion line and placed in an open field chamber ( Figure 7A ). Following a baseline period, mice were administered picrotoxin or vehicle (counterbalanced over 2 days with a day off in between sessions) into the NAc or the DS (data are presented together because similar effects were found; Figures S5 and S6 ). Low-dose picrotoxin administration had no significant effect on locomotion in control Drd2 sufficient to enhance locomotion in iMSN-Drd2KO compared to vehicle infusion (two-way repeated measures ANOVA; time 3 drug interaction, F 10,160 = 2.46, p = 0.009, n = 16; Figure 7D ). Indeed, after small dose of picrotoxin, iMSN-Drd2KO mice showed similar levels of locomotion compared to control animals (Drd2 loxP/loxP -picrotoxin, 12.9 ± 2.0 m / 20 min versus iMSNDrd2KO-picrotoxin, 13.3 ± 2.2 m / 20 min; post hoc test, p = 0.98; Figure 7E ). Thus, these data provide strong evidence that the enhanced intrastriatal GABAergic transmission is a critical contributor to the motor deficit.
Activation of G i -Coupled DREADD in iMSNs Reduced GABAergic Transmission and Restored Motor Output
D2Rs are G i -coupled receptors known to modulate neurotransmitter release at presynaptic terminals (Adrover et al., 2014; Dobbs et al., 2016) . We tested whether acute activation of G i signaling in iMSNs could revert the enhanced GABAergic transmission observed in iMSN-Drd2KO mice back to control levels. The G i -coupled DREADDs (hM4Di) were expressed in iMSNs of iMSN-Drd2KO mice ( Figures 8A and 8C ). The focus was in the NAc since this region showed increases in mIPSC frequency, amplitude, and tonic current in dMSNs ( Figure S6) . First, the ability of hM4Di to inhibit iMSN output was confirmed by measuring isolated GABA transmission from iMSN collateral axons. In brain slices where iMSNs also co-expressed ChR2, recordings were made from neighboring putative dMSNs to measure optogenetically evoked IPSCs (oIPSCs). The synthetic hM4Di agonist CNO (1 mM) decreased oIPSCs by 85% (one-way ANOVA, F 4,45 = 6.12, p = 0.0002, n = 6; Figures 8A and 8B) , demonstrating that G i -DREADD activation can robustly inhibit isolated iMSN inputs onto dMSNs. In agreement with previous results, we found enhanced tonic inward currents and mIPSC frequency in dMSNs from these iMSN-Drd2KO mice. A short pre-incubation (10-15 min) with CNO resulted in an overall reduction in the holding current density in dMSNs from À1.2 ± 0.2 pA/pF to À0.7 ± 0.1 pA/pF in slices pre-incubated in ACSF alone and ACSF + CNO, respectively (p = 0.045, n = 23 per group; Figure 8C ). Because reducing GABA transmission selectivity in iMSNs reduced the magnitude of tonic GABA-A-mediated current, these results indicate that GABA release from iMSNs contributes to the enhanced inhibition observed in mice lacking D2Rs. The same single acute administration of CNO had no effect on mIPSC amplitude or frequency (amplitude, 33 ± 2.0 pA in ACSF alone versus 30 ± 2.0 pA in ACSF + CNO; frequency, 2.0 ± 0.2 Hz in ACSF versus 1.8 ± 0.2 Hz in ACSF + CNO; p > 0.05; Figure 8C ). This result suggests that other sources of GABAergic innervation are also strengthened and/or there is a requirement for chronic G i signaling activation in order to achieve reversal of fast synaptic GABAergic transmission.
We also examined the effect of G i -DREADD activation on GPe firing rate in iMSN-Drd2KO mice. In this experiment, iMSNs were transduced to express the G i -DREADD based on modified kappa opioid receptor-DREADD called KORD (Vardy et al., 2015) , and in vivo recordings of GPe neurons were performed before and after intraperitoneal (i.p.) administration of vehicle or the KORD agonist SalvinorinB (SalB) (17 mg/kg i.p., dissolved in DMSO) ( Figure 8D ). There was a larger number of units that showed an increase in firing rate (>2 SD) after SalB administration (10/59 units) compared to vehicle (1/59 units), revealing a statistical trend for a drug increase in GPe firing (two-way repeated measures ANOVA; drug 3 time interaction, p = 0.12, 59 units, 2 mice; Figures 8E and 8F ). These data indicate that G i signaling activation in iMSNs is sufficient to partially revert the decrease in GPe firing observed in iMSN-Drd2KO mice.
The next experiment tested whether G i -DREADD activation in either the DS or NAc is sufficient to rescue the motor deficits of iMSN-Drd2KO mice. Before agonist administration, similar locomotion was seen in iMSN-Drd2KO mice expressing hM4Di or control mCherry in iMSNs in either the DS or NAc ( Figure S8 ). locomotor activity in iMSN-Drd2KO mice expressing hM4Di compared to those expressing mCherry in iMSNs (p < 0.05, n = 8-11; Figures 8G-8J ). This was roughly the same locomotor activity observed in iMSN-Drd2HET mice. Similar increase in locomotion was observed whether the DS or NAc was targeted in iMSN-Drd2KO (Figures 8G-8J ). CNO mainly increased the sustained locomotion by $70% (p < 0.05; Figures 8G-8J and S8). Interestingly, this manipulation had no significant effect on the novel exploration phase of locomotor response (p > 0.05; Figures 8G-8J and S8). It should be noted that activation of KORD by SalB during the GPe firing experiment also increased locomotion in iMSN-Drd2KO mice ( Figure S8 ). Thus, altogether the activation of G i -DREADD receptors only in iMSNs suppressed the enhanced tonic GABAergic transmission in the striatum and rescued the locomotor deficit observed in iMSNDrd2KO mice. Finally, we tested whether intrastriatal activation of G i -DREADD in iMSNs could rescue the motor deficit. Bilateral cannulas were implanted in DS of iMSN-Drd2KO mice expressing hM4Di or control mCherry in iMSNs ( Figures 8K and 8L ). Mice were habituated to being tethered and the open field chamber for several sessions before the testing began. iMSN-Drd2KO mice expressing mCherry in the DS served as control and showed a typical timedependent reduction in locomotion that is referred to as habituation following microinfusion of CNO (10 mM, 300 nL/side). In contrast, iMSN-Drd2KO mice expressing hM4Di showed a sustained increase in locomotion across time after CNO microinfusion, which prevented habituation ( Figure 8M ). The average speed (m/5 min) was significantly higher in iMSN-Drd2KO mice expressing hM4Di than mCherry during the last 20 min post-CNO microinfusion (2.37 ± 0.53 versus 1.3 ± 0.26 m/5 min for hM4Di and mCherry, respectively; one-tailed t test, p = 0.044, n = 9-10).
DISCUSSION
Selective deletion of D2Rs from iMSNs resulted in hypokenisa and bradykinesia, two characteristic motor deficits observed in Parkinson's disease patients and DA depletion models of Parkinson's disease (Smith et al., 2013) . These locomotor deficits are ameliorated in the presence of salient stimuli, resembling the paradoxical kinesia observed in Parkinson's patients (Bie nkiewicz et al., 2013) and also in agreement with observations made in DA depletion models of Parkinson's disease (Keefe et al., 1989; Rodríguez Díaz et al., 2001 ). However, in contrast to Parkinson's patients and DA depletion models, mice lacking D2Rs in iMSNs show normal DA levels and release properties. Thus, this targeted deletion approach has allowed us to dissect the selective contribution of this particular subpopulation of D2Rs within the basal ganglia to the regulation of motor output. The results show that activation of D2Rs in iMSNs is required for sustained locomotion.
D2Rs in iMSNs were shown to suppress lateral inhibition between MSNs (Dobbs et al., 2016; Tecuapetla et al., 2009) . These receptors are exquisitely positioned to exert potent control over MSN excitability and striatal output via regulation of GABA release. Indeed, we show that excision of D2Rs from iMSNs enhances inhibitory transmission in the striatum and the GPe and decreases in vivo MSN and GPe firing in awake-behaving animals. Interestingly, we showed that the D2-like agonist quinpirole does not alter the intrinsic excitability of iMSNs recorded from control animals in the presence of synaptic blockers, suggesting that regulation of somatodendritic ion channel conductances may not be the primary action of D2Rs in the striatum. Several studies using 6-OHDA lesions have reported an increase in MSN firing rate following DA depletion (Chen et al., 2001; Hull et al., 1974; Kish et al., 1999; Tseng et al., 2001) , in contrast to our observations. However, in agreement with our findings, other studies have observed decreased firing Chang et al., 2006) . Also in support of our results, treatment with a D2 antagonist reproduced the reduction in MSN firing in vitro and in freely moving rats (Yael et al., 2013) . The diverse results in the MSN firing data may be due to variations in the extent and duration of the DA depletion, which in turn could affect the degree of compensation such as upregulation of D2Rs in MSNs (Brené et al., 1994; Cadet et al., 1992; Narang and Wamsley, 1995; Schultz and Ungerstedt, 1978) , a compensatory mechanism that cannot occur in our mouse model.
The prediction from the classic ''go-no go'' model is that increased output of the indirect pathway with concurrent decreased output of the direct pathway underlies the motor impairments of DA depletion and Parkinson's disease patients. Although our observations appear to contradict this model at first glance, enhanced firing of iMSNs is only one possible mechanism for increasing indirect pathway output. Our data point to a dissociation between excitability/firing measured at the soma and GABA release measured from synaptic terminals. It suggests that GABA transmission from iMSNs is enhanced in iMSN-Drd2KO mice, despite decreased iMSN intrinsic excitability and baseline in vivo firing.
Our results are also consistent with the ''go-no go'' model in that they indicate a decrease in direct pathway output. However, in this case the reduction in dMSN output is largely due to hyper-GABAergic tone generated by a loss of D2R regulation. This hypothesis is supported by the results of the G i -DREADD rescue experiment (Figure 8 ) in which acute activation of G i -DREADDs in iMSNs reduced the size of the GABA-Amediated tonic current measured in dMSNs and enhanced locomotion in iMSN-Drd2KO mice. It is also important to note that other sources of GABA release in the striatum are likely to be potentiated and contribute to the phenotype, such as stronger FSI / MSN and GPe feedforward connectivity, as reported following 6-OHDA lesions (Fan et al., 2012; Gittis et al., 2011) . Independently of the source of GABA, our data favor the idea of a causal relationship between the enhanced GABA transmission and the decreased firing of both dMSNs and iMSNs leading to motor output deficits.
In summary, this study highlights the importance of DA regulation of intrastriatal inhibitory connectivity by D2Rs, often referred to as ''postsynaptic'' DA receptors. Here the results highlight its role at the level of presynaptic GABAergic terminals, as opposed to in the somata and dendrites, where these striatal D2Rs can potently suppress lateral inhibition and facilitate locomotion. This mechanism is rarely considered in the current models of basal ganglia function yet should be integrated in order to improve our understanding of this complex circuitry and the development of therapeutics for DA-related disease states. (legend continued on next page)
EXPERIMENTAL PROCEDURES
All procedures were performed in accordance with guidelines from the Animal Care and Use Committee of the National Institute on Alcohol Abuse and Alcoholism or the National Institute for Diabetes and Digestive and Kidney Diseases.
Animals
Mice (p60-p180) were group housed unless otherwise specified and kept under a 12 hr light cycle (6:30 ON/18:30 OFF) with food and water available ad libitum. For list of mouse lines, sources, and citations, see Supplemental Experimental Procedures.
Behavior
For all procedures required, mice were moved to a behavioral suite and allowed to acclimate for at least 30 min, and if handling was required, mice were handled 3-5 days prior to testing for habituation.
Locomotion and Exploration
Homecage locomotion was measured in mice that were individually housed several weeks prior to measurements. Mice were acclimated to the behavioral suite for 48 hr and then locomotion was measured using beam break detectors (Opto-M4, Columbus Instruments) for 2 consecutive days and averaged for 24 hr. Open field locomotion was measured in small (28 3 17 3 20 cm, length 3 width 3 height) polycarbonate chambers for 1 hr using beam break detectors or in a large (40 3 40 3 40 cm) acrylic/PVC chamber for 30 min using video monitoring.
Locomotion in Air-and Water-Filled Chambers
Opaque plastic circular chambers (20 cm diameter) were filled with warm water (30 C) or air. Each mouse was tested in two sessions (water and air counterbalanced across a 2-day period) and video monitored for 15 min. Videos were analyzed using Noldus Ethovision and mobility was defined as speed >2 cm/s over 15 sample frames, while immobility was defined by speed <0.75 cm/s.
Intrastriatal Microinfusion of Picrotoxin
Mice were tethered to an infusion line and placed in large open field chamber for 45 min baseline period. ACSF (vehicle) or picrotoxin (100 mM, counterbalanced across 2 days) was infused bilaterally via the cannula into the striatum (125-150 nL/side at 100 nL/min), and locomotion was assessed during 25 min post-infusion.
Novel Object Exploration
Mice were habituated to large open field chamber for 30 min and returned to homecage for 5 min, during which time a novel object was placed in the center of the open field. Animals were placed back into chamber and allowed to explore for 15 min while video recording. G i -DREADD Locomotion Rescue For systemic administration, mice received CNO (1 mg/kg, i.p., in saline) in their homecage 30 min prior to being placed in large open field chamber for 30 min. For intracranial administration, CNO (10 mM in ACSF) was infused via the cannula bilaterally (300 nL at 100 nL/min) while the animal was in the homecage, and the drug was allowed to diffuse for an additional 3 min after infusion was completed. Animals were then placed (untethered) in the large open field chamber for 70 min. Videos were analyzed using Noldus Ethovision software, and total distance travelled and speed were calculated.
Accelerating Rotarod
Mice were habituated to the rotarod (MedAssociates) for 1 min at 4 rpm. Following habituation, the rotarod accelerated from 4 to 40 rpm over 300 s. The trial was terminated at 300 s. Each trial was separated by $20 min, and there were 6 trials on day 1, followed by 4 trials on days 2-6. Additional details in Supplemental Experimental Procedures.
In Vitro Electrophysiology
Sagittal slices (240 mm) containing the dorsomedial striatum and NAc core were prepared from 8-to 16-week-old mice from the Drd2 loxP/loxP and iMSN-Drd2KO line that were crossed into a Drd1-tdTomato line. Slices were cut in ice-cold cutting solution as follows: 225 mM sucrose, 13.9 mM NaCl, 26.2 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 1.25 mM glucose, 2.5 mM KCl, 0.1 mM CaCl 2 , 4.9 mM MgCl 2 , and 3 mM kynurenic acid. Slices were maintained in oxygenated ACSF containing 124 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl 2 , 1.3 mM MgCl 2 , 26.2 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 0.4 mM ascorbic acid, and 20 mM glucose ($310-315 mOsm) at room temperature (RT) following a 1 hr recovery period at 33 C. Whole-cell voltage-clamp experiments were performed to measure optogenetically evoked IPSCs, mIPSCs, and mEPSCs, and current-clamp experiments were performed to measure intrinsic excitability. See Supplemental Experimental Procedures for list of internal solutions and drugs used for each experiment. Data were acquired at 5 kHz and filtered at 1 kHz using Multiclamp 700B (Molecular Devices). Data were analyzed using pClamp (Clampfit, v. 10.3) and MiniAnalysis (Synaptosoft, Inc.).
Fast-Scanning Cyclic Voltammetry
Brain slices and solutions were prepared as described in the electrophysiology section and recordings performed as previously described (Adrover et al., 2014) . The carbon-fiber electrode was held at À0.4 V, and a voltage ramp to and from 1.2 V (400 V/s) was delivered every 100 ms (10 Hz). Before recording, electrodes were conditioned by running the ramp at 60 Hz for 15 min and at 10 Hz for another 15 min and calibrated. Electrodes were calibrated using 1 mM DA. DA transients were evoked by electrical stimulation delivered through a glass microelectrode filled with ACSF. Either a single monophasic pulse (0.2 ms, 300 mA) or train of pulses (20 pulses, 20 Hz) was delivered to the slice in the absence or presence of the D2R antagonist sulpiride (1 mM). Data were acquired with a retrofitted headstage and Axon Amplifier using Multiclamp. Voltammetric analysis was done using custom-written procedures in Igor Pro software.
In Vivo Electrophysiology iMSN-Drd2KO and control (Adora2A-Cre +/À or Drd2 loxP/loxP ) mice were anesthetized with chloral hydrate (380 mg/kg) during surgery. One array of 32 Teflon-coated tungsten microwires (35 mm diameter) was implanted unilaterally in striatum (A/P, +0.8; Lat, +1.5; D/V, À2.6 mm from top of skull) or the globus pallidus (A/P, À0.5; Lat, +2.0; D/V, À3.5 mm from top of skull) and a stainless steel ground wire was implanted under the skull. For recordings, animals were placed in plastic chamber (25 cm diameter) or a novel mouse cage and allowed to move freely. In a subset of animals, ChR2 or KORD was also infused into the striatum (0.1 mm deeper than array) during surgery. Single units were discriminated using principal component analysis (Offline Sorter, Plexon). Spike channels were acquired at 40 kHz with 16 bit resolution, and the signal was band pass filtered at 150 Hz-8 kHz before spike sorting. MSNs and interneurons were identified based on waveform shape and average firing rate, similar to what has previously been described (Berke et al., 2004) . High-quality single-unit isolation was achieved, as assessed by measures of spike-sorting quality (Wheeler, 1998 ) (Davies-Bouldin index, J3 statistic).
Immunohistochemistry
Mice were intracardially perfused with PBS containing 10 U/mL Heparin until the liver cleared ($5 min) followed by 40 mL fixative solution (4% paraformaldehyde and 4% sucrose in 0.1 M PB) at 3 mL/min. Brain was removed, postfixed overnight, and then kept in 30% sucrose in 0.1 M PB. Coronal or sagittal floating sections (40 mm) were prepared using cryostat (Leica CM3050). Floating sections were washed in PBS and then blocked for 1 hr in 5% normal goat or donkey serum and 0.3% Triton-X in PBS at RT. Sections were then incubated in primary antibody for 12-18 hr at RT. Following 3 3 10 min washes in PBS, sections were incubated in goat or donkey secondary antibodies conjugated with AlexaFluor (1:500, Invitrogen) for 2 hr at RT. For a full list of antibodies, concentrations, and sources, see Supplemental Experimental Procedures. Slices were washed 3 3 10 min in PBS, then 2 3 10 min in 0.1 M PB. Images (512 3 512 or 1024 3 1024) were acquired using a confocal microscope (Zeiss LSM 510 META) and analyzed using ImageJ (NIH).
Statistics
Statistical analysis was performed in Prism (GraphPad) and Excel. Unless stated, two-tailed unpaired t tests were used. Otherwise, two-tailed paired t test, one-way ANOVAs or two-way repeated measures ANOVAs or one-tailed t tests were used when appropriate and stated. Two-way ANOVAs were followed up with Sidak-corrected t test comparisons. All data are presented as mean ± SEM. Results were considered significant at an alpha of 0.05. 
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